Paul Mickey Williams

机构：Frederick National Laboratory for Cancer Research · ORCID：0000-0002-3309-5988

发表论文 219 篇 · 总被引 13347 次 · h-index 42

代表论文

Larotrectinib in Patients With Tumors With NTRK Fusions: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol EAY131-Z1E (2026 · JCO Precision Oncology · 被引 2)
Crizotinib in Patients with Tumors with MET Amplification or Exon 14 Deletion: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocols C1 and C2 (2026 · Clinical Cancer Research · 被引 1)
Phase II Study of Dabrafenib and Trametinib in Patients With Tumors With BRAF V600E Mutations: Updated Results From NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol H (2026 · JCO Precision Oncology · 被引 1)
ERK1/2 Inhibitor Ulixertinib in Pancancer Patients with BRAF Fusions or Non-V600E/K Mutations: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol Z1L (2026 · Clinical Cancer Research)
Associations of Age With Tumor Genomic Characteristics in Relapsed/Refractory Cancers Interrogated With the NCI-MATCH Trial Targeted Gene Panel Assay (2026 · JCO Precision Oncology)
Perspectives From an Expert-Guided Discussion on Maximizing the Research Potential of Small Biopsy Tissue (2026 · JCO Precision Oncology)